EUDA Health Holdings Ltd: 10-Q filed 2022-05-25

Name: EUDA Health Holdings Ltd: 10-Q filed 2022-05-25
Creator: EUDA Health Holdings Ltd

What EUDA Health Holdings Ltd reported in its quarterly report filed 2022-05-25 (fiscal Q3 2022): 15 published measures, 36 facts as tagged in accession 0001493152-22-015019.

This filing

Form: 10-Q (quarterly report)
Filed: 2022-05-25
Fiscal period: fiscal Q3 2022
Accession: 0001493152-22-015019 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EUDA Health Holdings Ltd filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-04-30	86,944,172	USD
At 2021-07-31	428,920	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2022-04-30	3,879,253	USD
At 2021-07-31	399,797	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-04-30	-2,490,661	USD
At 2022-01-31	-2,009,023	USD
At 2021-10-31	-16,464	USD
At 2021-07-31	29,123	USD
At 2021-04-30	17,151	USD
At 2021-01-31	-1,189	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-04-30	546,887	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-02-01 to 2022-04-30	-472,989	USD	89
2021-08-01 to 2022-04-30	-743,466	USD	273
2021-11-01 to 2022-01-31	-224,890	USD	92
2021-08-01 to 2021-10-31	-45,587	USD	92
2021-02-01 to 2021-04-30	-6,660	USD	89
2021-01-21 to 2021-04-30	-7,849	USD	100
2021-01-21 to 2021-01-31	-1,189	USD	11

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2021-08-01 to 2022-04-30	-652,888	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2021-08-01 to 2022-04-30	87,449,775	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2021-08-01 to 2022-04-30	-86,250,000	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2022-04-30	-2,490,661	USD
At 2021-07-31	-8,377	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-02-01 to 2022-04-30	-481,638	USD	89
2021-08-01 to 2022-04-30	-752,861	USD	273
2021-02-01 to 2021-04-30	-6,660	USD	89
2021-01-21 to 2021-04-30	-7,849	USD	100

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-04-30	86,944,172	USD
At 2021-07-31	428,920	USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-04-30	2,448,500	shares
At 2021-07-31	2,156,250	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2021-07-31	37,500	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2022-04-30	5,560	USD
At 2021-07-31	3,640	USD

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2022-02-01 to 2022-04-30	8,649	USD	89
2021-08-01 to 2022-04-30	9,395	USD	273

Inspect the source

Entity: EUDA Health Holdings Ltd / CIK 0001847846
Captured: 2026-09-21T17:38:07.578Z
SEC response SHA-256: dd6f39e806463cb177a82e014aa8c86b0117f9aeb02824c94c43736aafd03565

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001847846.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))